Krintafel

Chemical Nametafenoquine
Dosage FormTablet (oral; 150 mg)
Drug ClassAntimalarials
SystemBlood
CompanyGlaxoSmithKline plc
Approval Year2018

Indication

  • To treat Plasmodium vivax malaria in conjunction with appropriate therapy for acute Plasmodium vivax in patients ≥ 16 years of age in cases that are not acute.
Last updated on 10/14/2020

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Krintafel (Tafenoquine) Prescribing Information 2018GlaxoSmithKline, Research Triangle Park, NC
Document TitleYearSource
Tafenoquine for primary and terminal prophylaxis of malaria in apparently healthy people: a systematic review. 2019Transactions of The Royal Society of Tropical Medicine and Hygiene